Provided by Tiger Trade Technology Pte. Ltd.

Vivos Therapeutics

1.64
-0.0700-4.09%
Volume:26.54K
Turnover:44.66K
Market Cap:18.73M
PE:-0.86
High:1.71
Open:1.71
Low:1.62
Close:1.71
52wk High:7.95
52wk Low:1.42
Shares:11.42M
Float Shares:9.35M
Volume Ratio:0.90
T/O Rate:0.28%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.9054
EPS(LYR):-2.2184
ROE:-335.45%
ROA:-49.76%
PB:7.40
PE(LYR):-0.74

Loading ...

Vivos Therapeutics Appoints Gregg Johnson to Board

TIPRANKS
·
Feb 07

BUZZ-U.S. STOCKS ON THE MOVE-Netflix, FirstCash Holdings, CF Bankshares

Reuters
·
Feb 06

Vivos Therapeutics Partners with SoundHealth to Expand Access to Sleep and Allergy Technologies

Reuters
·
Feb 05

Vivos Therapeutics and Soundhealth Announce Collaboration to Expand Access to Soundhealth’s Groundbreaking FDA-Cleared Allergy and Sleep Technologies

THOMSON REUTERS
·
Feb 05

Vivos Therapeutics Announces Closing of Exercise of Warrants for $4.64 Million Gross Proceeds

GlobeNewswire
·
Jan 21

Vivos Therapeutics Completes Warrant Inducement Financing Transaction

TIPRANKS
·
Jan 21

Vivos Therapeutics Raises $4.6 Million Through Warrant Exercise at Reduced Price

Reuters
·
Jan 21

Vivos Therapeutics Secures Convertible Bridge Financing Facility

TIPRANKS
·
Jan 17

Vivos Therapeutics Secures $5.5 Million in Unregistered Private Placement

Reuters
·
Jan 17

Vivos Therapeutics Raises $4.64 Million Through Warrant Exercise

Reuters
·
Jan 16

Press Release: Vivos Therapeutics Announces Exercise of Warrants for $4.64 Million Gross Proceeds

Dow Jones
·
Jan 16

Alliance Global Partners Sticks to Its Hold Rating for Vivos Therapeutics (VVOS)

TIPRANKS
·
Jan 09

Vivos Therapeutics Opens New Sleep Center in Auburn Hills, Michigan

Reuters
·
Dec 16, 2025

Vivos Therapeutics Executives Join Water Tower Research Online Fireside Chat

Reuters
·
Dec 16, 2025

Vivos Therapeutics Secures $2.1 Million Unsecured Loan from Avondale Capital

Reuters
·
Dec 06, 2025

Vivos Therapeutics Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 03, 2025

Vivos Therapeutics Reports Strong Q3 Growth Amid Challenges

TIPRANKS
·
Nov 22, 2025

Vivos Therapeutics Reports Revenue Growth Amid Strategic Shift

TIPRANKS
·
Nov 20, 2025

Vivos Therapeutics Reports 78% Sequential Revenue Growth in Third Quarter 2025

Reuters
·
Nov 20, 2025

Vivos Therapeutics Q3 revenue rises, helped by SCN acquisition

Reuters
·
Nov 20, 2025